01
iPS TECHNOLOGY
Understanding human disease
Patient-derived iPS cells make it possible to study the individuality and human-specific characteristics of disease. This foundation can support target discovery and therapeutic evaluation.
TECHNOLOGY
Technology
We use patient-derived iPS cells to understand disease, then connect those insights to gene therapy. This is the research approach behind Time Biotechnologies.
OUR APPROACH
From patients to treatment.
From research grounded in human disease to therapies designed to act on underlying causes, we connect distinct technologies in one continuous process.
- 01 PATIENT-DERIVED CELLS
Patient-derived cells
Disease information carried by patient cells forms the starting point of our research.
- 02 iPS TECHNOLOGY
Disease research with iPS cells
We derive disease-relevant cells and observe pathological processes at the cellular level.
- 03 DISEASE INSIGHT
Therapeutic insight
We deepen our understanding of disease and search for ways to act on its underlying causes.
- 04 GENE THERAPY
Translation into gene therapy
We connect scientific insight to approaches that pursue fundamental treatment.
RESEARCH FOUNDATIONS
Two research foundations
By combining iPS technology and gene therapy, we aim to move the time to treatment forward.
02
GENE THERAPY
Acting on disease causes
We pursue treatments that go beyond symptom relief by acting on underlying causes, translating insights from iPS-based disease research into therapeutic design.
INFORMATION
About our research
Details on individual programs, target diseases, and development status will be published when ready. Please contact us about collaborative or contract research.